The results showed that MMP-9 activity was significantly increased after ischemia and further enhanced by delayed tPA, and these effects were profoundly inhibited by combination treatment of tPA + J147 and J147 (Figure 3B), with a substantial improvement of collagen-IV degradation after stroke (Figure 3C). The gene discussed is PLAT; the disease is stroke disorder.